Journal List > Korean J Anesthesiol > v.73(6) > 1156452

Ong, Lim, Ong, and Kam: Anesthesia guidelines for COVID-19 patients: a narrative review and appraisal

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has challenged health systems globally and prompted the publication of several guidelines. The experiences of our international colleagues should be utilized to protect patients and healthcare workers. The primary aim of this article is to appraise national guidelines for the perioperative anesthetic management of patients with COVID-19 so that they can be enhanced for the management of any resurgence of the epidemic. PubMed and EMBASE databases were systematically searched for guidelines related to SARS-CoV and SARS-CoV-2. Additionally, the World Federation Society of Anesthesiologists COVID-19 resource webpage was searched for national guidelines; the search was expanded to include countries with a high incidence of SARS-CoV. The guidelines were evaluated using the Appraisal of Guidelines for Research and Evaluation II tool. Guidelines from Australia, Canada, China, India, Italy, South Africa, South Korea, Taiwan, the United Kingdom, and the United States of America were evaluated. All the guidelines focused predominantly on intubation and infection control. The scope and purpose of guidelines from China were the most comprehensive. The UK and South Africa provided the best clarity. Editorial independence, the rigor of development, and applicability scored poorly. Heterogeneity and gaps pertaining to preoperative screening, anesthesia technique, subspecialty anesthesia, and the lack of auditing of guidelines were identified. Evidence supporting the recommendations was weak. Early guidelines for the anesthetic management of COVID-19 patients lacked quality and a robust reporting framework. As new evidence emerges, national guidelines should be updated to enhance rigor, clarity, and applicability.

Introduction

China reported the first outbreak of the novel severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) in Wuhan on 7 January 2020 [1]. As of 25 June 2020, coronavirus disease 2019 (COVID-19) had become a pandemic with more than 9 million cases with 2% critically ill and 9% deceased [2]. Importantly, healthcare workers accounted for 3.8% of the cases in China and 11% in Italy [3]. Virus transmission is through respiratory droplets and fomites, which places anesthetic staff at a high risk of nosocomial infection. Although the virus has been reported to be air-borne [4], this has not yet been confirmed in clinical studies.
Following the rapid and global spread of the virus, numerous guidelines have been published by national anesthesia societies to provide anesthetists with insights into the management of COVID-19 patients and the risk of infection during aerosol-generating procedures (intubation, extubation, airway suctioning) associated with anesthesia [5]. Ideally, guidelines should have scientific rigor, and they should be presented with clarity. They should also apply to practitioners internationally, irrespective of the minor variations in practice. An objective framework for developing and appraising clinical guidelines is provided by the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool [6]. As various countries move from the containment phase to the gradual relaxation of community restrictions, the second surge of infections is anticipated.
The primary aim of our review was to appraise national guidelines on the anesthetic considerations for COVID-19 patients presenting for surgery and evaluate their quality with the AGREE II tool. Through updates, guidelines can be refined to ensure that they are more robust, and they can equip anesthetists for the potential viral resurgence.

Materials and Methods

Search strategy and selection of sources of evidence

We conducted a systematic search of the PubMed and EMBASE databases using the combination of Medical Subject Heading (MeSH) and keywords ([“anesthesia” or “anesthesiology”] OR [“airway management”] OR [“intubation”]) AND ([“SARS” OR “SARS-CoV” OR “SARS-CoV-2” OR “COVID-19” OR “Coronavirus”]) for guidelines/studies published between 1 Jan 2002 and 16 May 2020. To capture new guidelines that had not been indexed in these databases, national anesthesia organizations, with links to their official websites listed on the World Federation of Society of Anesthesiologists (WFSA) [7] COVID-19 resource webpage (up to 28 May 2020), were interrogated because it represents anesthesia societies from over 150 countries. We also expanded our search for guidelines from countries (China, Hong Kong, Singapore, and Taiwan) that were affected by the SARS-CoV epidemic in 2003 [8]. Guidelines from Hong Kong and Singapore, which reported SARS previously, were not endorsed by their official national societies, and they were excluded. The bibliographies of the retrieved articles were manually screened for additional relevant material.

Eligibility criteria

Only articles written in English and Chinese were included because the two co-authors who conducted the search were proficient in both languages. Articles that reported relevant aspects of perioperative anesthetic management of patients with COVID-19 were included. Two reviewers (SO and WYL) conducted the search independently and screened all article types for eligibility using their titles and abstracts. Duplicate and irrelevant articles were excluded. Articles that did not address the primary objective and those that were correspondences and editorials were also excluded. Discrepancies were discussed and resolved by PK.

Critical appraisal of sources of evidence

SO and PK independently appraised each eligible national guideline using the AGREE II instrument [6] (Supplementary Table 1). The AGREE II instrument has six domains (with 23 items) and two global rating items. The six domains were scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. Each item in the domain is scored on a seven-point scale (1 = minimum to 7 = maximum). Total scores were scaled to a percentage of the maximum score in each domain; for example, 0% if each reviewer scored 1 and 100% if each reviewer scored 7. The AGREE II instrument has been validated and tested for inter-rater reliability.
In addition, full manuscripts of extracted articles from the literature search were analyzed independently by SO and WYL and graded according to the level of evidence as defined by the Centre for Evidence-Based Medicine, Oxford [9].

Results

Nineteen national guidelines from Australia, Canada, China, India, Italy, South Africa, South Korea, Taiwan, the UK, and the USA described the anesthetic management of COVID-19 patients [1028]. China had the highest score for Scope and Purpose of guidelines followed by South Korea and the UK. The UK and South Africa scored the highest for the Clarity of guidelines. Among the domains, editorial independence had the lowest score, followed by rigor of development and applicability. Spearman correlation analysis of reviewer scores of all domain items demonstrated good inter-rater reliability (ρ = 0.714, P < 0.001, 95% CI: 0.436–0.868). A summary of the results is provided in Table 1.
There was a paucity of high-quality evidence supporting the current recommendations. Of the 63 articles retrieved from the literature search, only one systematic review (level 2) in 2012 related aerosol-generating procedures to the infections of health care workers [29], and one prospective single-center study (level 3) in 2006 focused on simulation [30]. The remainder of the reports were predominantly retrospective studies, case reports/series (level 4), and expert opinions (level 5) that focused on infection control and intubation. The results of the literature search are shown in Supplementary Table 2.

Guidelines on preoperative management

Preoperative evaluation, screening, and prioritization for surgery

The details on preoperative guidance varied. China and India detailed preoperative screening of history, symptoms, and investigations while South Africa used a brief checklist [15,17,20]. Australia recommended using telemedicine for preoperative assessment, counseling, consent, and a thorough airway assessment [10]. The UK through the Difficult Airway Society focused specifically on the MACOCHA (Mallampati III or IV; Apnea syndrome [obstructive]; Cervical spine limitation; Opening mouth-3 cm; Coma; Hypoxia; Anesthesiologist-non trained) score to assess and predict a difficult airway [24,31]. Only the USA linked preoperative screening with viral testing and prioritization for surgery involving a multidisciplinary team [26]. Recommendations on scheduling elective surgery during the pandemic were provided by Canada, India, South Africa, the UK, and the USA [12,17,20,24,26].

Infection control and personal protective equipment

This was the focus of all the guidelines. All countries recommended airborne precautions and Personal protective equipment (PPE) training [1028]. There was unanimous agreement on the use of full PPE (N95 mask or powered air-purifying respirator (PAPR), face shield or goggles, gown, hat, double gloves) for aerosol-generating procedures and hand hygiene when donning and after doffing PPE [1028]. All countries (apart from India and South Korea), recommended a buddy system for PPE donning. High-risk healthcare personnel who were pregnant, immunocompromised, or older than 60 years with cardiorespiratory diseases were advised by the UK to refrain from airway management [23,24]. The number and position of staff present in the inner and the outer rooms, the types of PPE, including the position of equipment and monitors, were detailed by Italy and the UK [19,24]. Other recommendations included using a negative pressure operating theater with warning signs [1021,2328], placing a hydrophobic filter interposed between the face mask/endotracheal tube and the breathing circuit or the reservoir bag [1028], and using disposable equipment [1016,1828] where possible. A clear plastic sheet to limit the aerosol spread and the use of forced-air warming blankets only in intubated patients were recommended by Australia [10].

Training and resource planning

Simulation training for the provision of anesthetic care was advocated by Australia, Canada, China, India, Italy, the UK, and the USA [1019,2328]. In addition, team briefing before surgery was recommended by Australia, Italy, South Africa, the UK, and the USA [10,11,18,2328]. China, India, and South Korea addressed fatigue by deploying several airway and anesthetic teams to support hospitals and operating theaters [1417,21]. All guidelines (except those from Canada and Taiwan) detailed the most direct route for patient transfer to the operating theatre: bypassing the holding area with the patient wearing a surgical mask [10,11,1428].

Evidence

Apart from one level 2 and one level 3 evidence studies, the evidence relating to preoperative management was weak (level 4 and 5 evidence), and it focused on infection control [29,30]. Reports from the SARS outbreak in 2003 detailed risk factors for the infection of healthcare workers related to PPE use and aerosol generation [29,30,32-34]. Recent reviews on the preoperative management of COVID-19 patients also described operating room optimization and infection control and the rational use of PPE [35,36].

Guidelines on intraoperative management

Intubation

All guidelines focused on the reduction of aerosol generation during procedures and limiting the exposure of healthcare personnel [1028]. Recommendations included a rapid sequence induction and intubation by the most experienced airway personnel and the use of a videolaryngoscope [1028]. Canada and the UK recommended using intravenous ketamine for induction in patients with hemodynamic instability [12,23]. Manual ventilation was to be avoided and, if required, small tidal volumes were to be delivered via two-handed facemask ventilation, with the VE hand position preferred to the C hand position [24] for a better mask seal. The Difficult Airway Society in the UK also recommended meticulous attention to preoxygenation, including optimizing patient positioning at induction to maximize a safe apnea time [24]. Only Italy suggested apneic nasal oxygenation delivery at a flow rate of 3 L/min during airway manipulation [18]. Positive pressure ventilation was only to be commenced after intubation and inflation of the tracheal tube cuff [1020,2228] to at least 5 cmH2O above the peak inspiratory pressure [24]. Awake fiberoptic intubation, including the use of high-flow nasal oxygen and non-invasive ventilation was discouraged by all guidelines (except for Canada and South Africa). Only Australia, Italy, and the UK provided specific recommendations for the management of a difficult airway [10,11,18,19,23,24]. These included using the VORTEX approach [37], intubation via a supraglottic airway device (SAD), and employing the scalpel bougie over the needle cannula approach in front of neck access in “cannot intubate, cannot oxygenate” scenarios [10,19,24]. Other heterogeneous recommendations included a smaller sized endotracheal tube, avoidance of cricoid pressure (to minimize coughing) [19], and loading the endotracheal tube routinely with an introducer [10,11].

Use of SAD

There is no consensus on its use as the primary airway device for general anesthesia. China recommended its use [15]; Australia, Canada, Italy, and the UK recommended it only for airway rescue [10,12,19,23,24]. If a second-generation device is used, ensuring a leak-free seal is recommended [24].

Regional anesthesia

Regional anesthesia, where possible, has been advocated by Australia, China, India, and the USA [10,1417,2528]. Thrombocytopenia and coagulopathy should be excluded before neuraxial techniques, especially in patients with severe COVID-19 disease [38]. Although SARS-CoV-2 has been demonstrated in cerebrospinal fluid and brain tissue on autopsy, spinal anesthesia in obstetric parturients with COVID-19 has been reported to be safe [39]. For peripheral nerve blocks near the head and neck area, airborne precautions may be considered [40]. In addition, confirming the success of the block reduces the need for emergent conversion to general anesthesia [40].

Extubation

Extubation recommendations targeted at minimizing cough varied, and they included deep extubation, SAD exchange, administration of opioids, lidocaine, dexmedetomidine [10,11,24], glycopyrrolate [22], and prophylactic antiemetics [12,17,27,28].

Evidence

Evidence supporting airway management and endotracheal intubation was initially derived from a systematic review on aerosol-generating procedures and infection in healthcare workers (level 2 evidence) and case reports (level 4 evidence) published on SARS [29,33,34,4144]. Recent reports on COVID-19 patients (level 4 and 5 evidence) have been published [1416,4551]. A recent retrospective review (which included an expert panel) of the emergency intubation of 202 patients with COVID-19 reported that hypoxemia (oxygen saturation < 90%) was common and associated with hypotension, cardiac arrest, and pneumothorax [14]. The authors recommended head elevation for intubation with propofol dose reduction, fluid boluses, or inotropes (to avoid hypotension). A ventilation protective strategy utilizing small tidal volumes to minimize barotrauma was recommended [14].

Guidelines on postoperative management

Patient transfer

Most guidelines proposed that the patient should be recovered in the operating theater [10,11,15,16,2528]. If disconnection from the breathing circuit is required, clamping the endotracheal tube before disconnection was recommended [1012,19,24,26,27].

Postoperative cleaning and disinfection

Australia, Canada, China, India, Taiwan, the UK, and USA detailed environmental disinfection [1017,2228]. Australia and the UK recommended waiting 20 to 30 minutes between cases to allow for operating theater cleaning and air changes [10,23]. All guidelines advocated the disposal of waste into labeled bins [1028]. Additionally, Australia, China, India, South Africa, South Korea, Taiwan, and the USA recommended sealing all contaminated equipment for disinfection in double zip-locked bags [10,11,15,17,2022,26]. China and South Korea proposed the replacements of the end-tidal carbon dioxide sample line and water trap [15,21].

Staff monitoring and welfare

Australia, Italy, the UK, and the USA [10,19,23,26] recommended a team debriefing event, while Canada encouraged incident reporting of adverse events [12]. With regards to staff surveillance, Australia and the USA required staff to maintain a logbook of clinical exposure, while China required daily surveillance of temperature and respiratory symptoms [10,15,16,26,28]. Additionally, Australia, Canada, South Africa, the UK, and the USA provided support services on mental well-being [10,12,20,23,26].

Evidence

There was little evidence on postoperative management apart from a retrospective study (level 4 evidence) from China that reported surveillance and a 14-day quarantine of a team of anesthesiologists who performed intubation on all COVID-19 patients in two hospitals [52].
A summary of guidelines for the anesthetic management of COVID-19 patients is provided in Tables 24.

Guidelines on subspecialty anesthesia

Obstetric anesthesia

National guidelines on the perioperative anesthetic management of obstetric patients with COVID-19 were scarce. Australia, China, Taiwan, the UK, and the USA recommended neuraxial anesthesia as the technique of choice for cesarean delivery [10,15,22,23,2528]. The use of nitrous oxide/oxygen mixture for labor analgesia was controversial. The UK endorsed its use with a viral filter, but Australia and Taiwan did not [10,22,23]. Evidence from retrieved articles was mainly of level 4 and 5 quality. An expert panel review recommended screening patients for COVID-19 symptoms remotely and observing droplet and contact precautions in the labor ward [53]. Parturients were to wear surgical masks as increased ventilation during labor and symptoms could predispose to airborne transmission [54]. Two studies reported safe administration of epidural and spinal in COVID-19 patients who underwent cesarean section [39,55]. However, a higher incidence of maternal hypotension was reported [55]. Combined spinal and epidural was recommended for anticipated prolonged procedures to minimize conversion to general anesthesia [56]. Thrombocytopenia, which may be present in COVID-19 infections, was to be excluded. Epidural was recommended for labor analgesia to reduce the need for general anesthesia if urgent delivery is required. Category 1 cesarean section delivery should be avoided by close fetal monitoring [42,56]. Patients should be informed of potential delays due to PPE donning [42].

Pediatric anesthesia

Australia, Canada, and the UK provided guidelines for pediatric anesthesia [10,13,23]. Aerosol generation from crying was to be minimized by sedation, parental presence, and deep extubation [10,13]. Inhalation induction was to be best performed with a circle system, utilizing the lowest gas flows. Airway management was to be performed by trained pediatric staff, and a cuffed endotracheal was recommended [10,13,23]. Recommendations for difficult airway management included using video laryngoscopy primarily, followed by fiberoptic intubation through a SAD, combined video laryngoscopy with fiberoptic bronchoscopy, and fiberoptic bronchoscopy alone [13]. The UK also highlighted the need to exclude pediatric multisystem inflammatory syndrome associated with COVID-19 [23]. The literature review revealed only expert opinions and narrative reviews (level 5 evidence) that supported the guidelines from Australia, Canada, and the UK [13,57].

Cardiothoracic anesthesia

Advanced hemodynamic monitoring such as transesophageal echocardiography can be used to guide fluid therapy and vasoactive drugs, especially for COVID-19 patients with multi-organ dysfunction presenting for cardiac surgery. In addition, blood conservation and rigorous evaluation of coagulation are needed for coagulation abnormalities [58]. For thoracic anesthesia, viral filters and clamps should be placed on the double-lumen tube before opening it to the atmosphere so that the release of positive pressure within the lung occurs through a viral filter. In addition, ventilation should be withheld and a swivel connector with a self-sealing valve should be used if the breathing circuit is to be accessed for procedures. Bronchoscopes are significantly contaminated, and disposable flexible bronchoscopes should be used where possible. Suctioning of the airways should be performed before reversing neuromuscular blockades [59,60].

Neuroanesthesia

Full PPE for aerosol-generating procedures should be used for trans-sphenoidal surgeries, as there is a high incidence of viral shedding. Patients undergoing awake craniotomy should be lightly sedated to avoid an emergent airway, and low-dose lidocaine or remifentanil can be used to minimize coughing. For the endovascular treatment of acute ischemic stroke, a low threshold for general anesthesia with intubation by airway personnel in a negative pressure room is preferred over the urgent conversion from sedation [61]. In addition, a lead gown can be worn under the PPE gown [62].

Anesthesia for otolaryngology

For airway surgery such as airway dilatation and tracheostomy, closed-loop communication between the surgeon and anesthesiologist is important to ensure that ventilation is held-off every time the endotracheal cuff is deflated, the tube is removed, or the circuit is disconnected [63].

Trauma anesthesia

Regional anesthesia is recommended where possible. Cricoid pressure during induction of general anesthesia should be used with caution, as it can stimulate coughing. Blood conservation is recommended and thromboprophylaxis should be instituted where possible [38].

Discussion

The strength of this review is that it provides a comprehensive appraisal of all the available guidelines; it also summarizes their strengths and limitations. Our review found that national guidelines for the anesthetic management of COVID-19 patients were moderately comprehensive, but they scored poorly for rigor of development, editorial independence, and applicability. Evidence underpinning guidelines was weak, leading to heterogeneity in recommendations. Gaps in preoperative screening, prioritization for surgery, and anesthesia for specific groups were identified and addressed, albeit with low-quality evidence consisting of retrospective studies, case reports, narrative reviews, and expert opinions.
The Institute of Medicine defines clinical guidelines as “statements that include recommendations, intended to optimize patient care, that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options” [64]. Clinical guidelines assist physicians in providing the best care, and they should adhere to a robust reporting framework. Given the rapid spread of the pandemic, initial guidelines were undoubtedly subjected to time-sensitive pressure in development and publication. As the virus is highly contagious, early guidelines focused on defining aerosol-generating procedures, mitigating aerosolization, and appropriate PPE and infection control practices. These were largely based on retrospective studies and case series during the SARS outbreak in 2003 [30,33,34,4244]. These initial guidelines have served their purpose in successfully limiting disease spread to healthcare workers. Moving forward, national guidelines should be updated as new data emerge to include the entire perioperative process. Dagens et al. [65] suggested that pandemic guidelines should have transparent timelines for revision and amendment to ensure that they are more robust, especially for the potential viral resurgence. The recommendations should describe how they were derived and indicate their strengths and limitations and whether they were reviewed by experts, including infectious disease physicians and epidemiologists. Importantly, recommendations should be linked to an evaluation of supporting evidence and presented clearly with the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) system [66]. GRADE is widely used by many organizations globally, and it is a transparent and reproducible framework that helps clinicians to understand the underlying logic and principles of the guidelines. The GRADE system comprises a two-level representation of the strength of recommendation (weak or strong) and a four-level representation of the certainty of the evidence (very low, low, moderate, and high) [67]. In addition, conflict of interest, which is essential for any scientific publication, should be disclosed, as many involved experts may have industry affiliations. Non-declaration implies bias, and it reduces the quality and reliability of the recommendations. Contributions from experts in subspecialty interest groups make national guidelines more inclusive and comprehensive. Although attempts to address difficult airway management were addressed by the Difficult Airway Society in the UK and Safe Airway Society in Australia and New Zealand, guidance for other patient groups was scarce.
With countries resuming elective surgeries, gaps in current guidelines would need to be addressed. Of relevance would be preoperative screening, which has important implications for resource utilization, especially PPE, processes, facilities, and manpower. Preoperative screening for COVID-19 and prioritization for surgery is also important, as morbidity and mortality have been reported in pre-symptomatic carriers who have undergone elective surgeries [68]. The USA has proposed two approaches to the perioperative testing of COVID-19 depending on the local prevalence of SARS-CoV-2. The American College of Surgeons recommends that a committee comprising surgeons, anesthesiologists, and nurses (guided by the Elective Surgery Acuity Scale) should assist with the prioritization of patients for surgery [69].
Categorizing COVID-19 to mild, moderate, severe, or critical may also help to refine anesthetic plans [70]. For COVID-19 patients with moderate to severe pneumonia, careful airway assessment is important, as hypoxemia during intubation is common and the options for oxygenation or awake intubation are limited. Critically ill patients with organ dysfunction would require preemptive inotropes, fluid resuscitation, careful titration of drugs, and a lung-protective ventilation strategy [14].
Areas of controversy relating to anesthetic technique, the use of airway devices, the extent of aerosol dispersion, and the management of specific groups require further research and guidance updates as new evidence emerges. Further research on temperature, blood, and fluid management, including the degree of staff surveillance for infection and burnout is also needed.
This review was limited by the language restriction of our search and the quality of evidence available. Evidence was mostly from retrospective studies involving small samples, case reports, narrative reviews, and expert opinions.

Conclusion

National anesthetic guidelines published in the early phase of the COVID-19 pandemic were largely guided by weak evidence, and they lacked robust reporting. As countries move into easing lockdown during the second phase of the pandemic, recommendations need to be updated as new data become available. Guidelines should be subjected to established grading and appraisal systems such as GRADE and AGREE II to provide clarity, especially during a pandemic.

ACKNOWLEDGMENTS

Benjamin YL Thong, for assistance with the production of the Tables.

Notes

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Author Contributions

Sharon Ong (Conceptualization; Data curation; Formal analysis; Methodology; Project administration; Supervision; Validation; Writing – original draft; Writing – review & editing)

Wan Yen Lim (Data curation; Formal analysis; Methodology; Validation; Writing – original draft; Writing – review & editing)

John Ong (Data curation; Formal analysis; Methodology; Supervision; Validation; Writing – review & editing)

Peter Kam (Conceptualization; Formal analysis; Investigation; Methodology; Supervision; Validation; Writing – review & editing)

Supplementary Materials

Supplementary Table 1.
AGREE II Instrument [6]
kja-20354-suppl1.pdf
Supplementary Table 2.
Combined results from guidelines and database search
kja-20354-suppl2.pdf

References

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; Feb. 382:727–33.
crossref
2. Coronavirus Update (Live): 282,769 Cases and 11,822 Deaths from COVID-19 Virus Outbreak [Internet]. Worldometer [updated 2020 Nov 5; cited 2020 Jun 28]. Available from https://www.worldometers.info/coronavirus/.
3. The Lancet. COVID-19: protecting health-care workers. Lancet. 2020; 395:922.
4. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382:1564–7.
crossref
5. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) [Internet]. Atlanta: CDC;[updated 2020 Nov 4; cited 2020 May 28]. Available from https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Finfection-control-faq.html. 2020.
6. Brouwers MC, Kerkvliet K, Spithoff K; AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016; 352:i1152.
crossref
7. World Federation Of Societies of Anaesthesiologists. Coronavirus - guidance for anaesthesia and perioperative care providers [Internet]. London: WFSA;[cited 2020 May 28]. Available from https://www.wfsahq.org/resources/coronavirus.
8. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 [Internet]. Geneva: WHO;[cited 2020 May 28]. Available from https://www.who.int/csr/sars/country/table2004_04_21/en/.
9. Durieux N, Pasluea F, Howick J. OCEBM Levels of Evidence [Internet]. Oxford: CEBM;[cited 2020 May 28]. Available from https://www.cebm.net/2016/05/ocebm-levels-of-evidence/.
10. Australian Society of Anaesthesiologists. COVID-19 Updates [Internet]. Sydney: ASA;[updated 2020 Oct 24; cited 2020 May 28]. Available from https://asa.org.au/covid-19-updates/.
11. Brewster DJ, Chrimes NC, Do TB, Fraser K, Groombridge CJ, Higgs A, et al. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group. Med J Aust. 2020; 212:472–81.
crossref
12. Canadian Anesthesiologists’ Society. Coronavirus Tips and Guidelines [Internet]. Toronto: CAS;[cited 2020 May 28]. Available from https://www.cas.ca/en/practice-resources/news/cas-articles/2020/coronavirus-tips-and-guidelines.
13. Matava CT, Kovatsis PG, Lee JK, Castro P, Denning S, Yu J, et al. Pediatric airway management in COVID-19 patients: Consensus Guidelines From the Society for Pediatric Anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society. Anesth Analg. 2020; 131:61–73.
14. Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, et al. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. Br J Anaesth. 2020; 125:e28–37.
crossref
15. Chen X, Liu Y, Gong Y, Guo X, Zuo M, Li J, et al. Perioperative management of patients infected with the novel coronavirus: recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists. Anesthesiology. 2020; 132:1307–16.
16. Zuo MZ, Huang YG, Ma WH, Xue ZG, Zhang JQ, Gong YH, et al. Expert recommendations for tracheal intubation in critically ill patients with noval coronavirus disease 2019. Chin Med Sci J. 2020; 35:105–9.
crossref
17. Malhotra N, Joshi M, Datta R, Bajwa SJ, Mehdiratta L. Indian Society of Anaesthesiologists (ISA National) Advisory and Position Statement regarding COVID-19. Indian J Anaesth. 2020; 64:259–63.
crossref
18. European Society of Anaesthesiology and Intensive Care. Airway Management in patients suffering from COVID-19 [Internet]. Brussels: ESAIC;2020 Mar 11 [cited 2020 May 28]. Available from https://www.esahq.org/esa-news/covid-19-airway-management/.
19. Sorbello M, El-Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, et al. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020; 75:724–32.
crossref
20. South African Society of Anesthesiologists. SASA Covid-19 Updates [Internet]. Glenashley: SASA;[cited 2020 May 28]. Available from https://sasacovid19.com/.
21. Kim HJ, Ko JS, Seo H, Kim TY. Guidelines for the control and prevention of coronavirus disease (COVID-19) transmission in surgical and anesthetic settings. Korean J Anesthesiol. 2020; 73:271–4.
crossref
22. Taiwan Society of Anesthesiologists. Recommendations for airway management/intubation for COVID-19 patients [Internet]. Taiwan: TSA;[cited 2020 May 28]. Available from https://www.anesth.org.tw/.
23. Association of Anaesthestists. Anaesthetic Management of Patients During a COVID-19 Outbreak [Internet]. London: [updated 2020 Apr 2; cited 2020 May 28]. Available from https://anaesthetists.org/Home/Resources-publications/Anaesthetic-Management-of-Patients-During-a-COVID-19-Outbreak.
24. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia. 2020; 75:785–99.
25. Anesthesia Patient Safety Foundation 2020. Perioperative Considerations for the 2019 Novel Coronavirus (COVID-19) [Internet]. Rochester: APSF;2020 Feb 12 [updated 2020 Mar 10; cited 2020 May 28]. Available from https://www.apsf.org/news-updates/perioperative-considerations-for-the-2019-novel-coronavirus-covid-19/.
26. American Society of Anesthesiologists. COVID-19 Resources [Internet]. Schaumburg: ASA;[cited 2020 May 28]. Available from https://www.asahq.org/about-asa/governance-and-committees/asa-committees/committee-on-occupational-health/coronavirus.
27. American Association of Nurse Anesthetists. Anesthesia Care of the Patient with Coronavirus Disease 2019 (COVID-19) [Internet]. Park Ridge: AANA;[cited 2020 May 28]. Available from https://www.aana.com/practice/clinical-practice-resources/anesthesia-care-of-the-patient-with-coronavirus-disease-2019-(covid-19).
28. Society for Obstetric Anesthesia and Perinatology. Interim Considerations for Obstetric Anesthesia Care Related to COVID19 - SOAP [Internet]. SOAP;[cited 2020 May 28]. Available from https://soap.org/education/provider-education/expert-summaries/interim-considerations-for-obstetric-anesthesia-care-related-to-covid19/.
29. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012; 7:e35797.
crossref
30. Abrahamson SD, Canzian S, Brunet F. Using simulation for training and to change protocol during the outbreak of severe acute respiratory syndrome. Crit Care. 2006; 10:R3.
31. De Jong A, Molinari N, Terzi N, Mongardon N, Arnal JM, Guitton C, et al. Early identification of patients at risk for difficult intubation in the intensive care unit: development and validation of the MACOCHA score in a multicenter cohort study. Am J Respir Crit Care Med. 2013; 187:832–9.
32. Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anaesth. 2020; 67:568–76.
crossref
33. Caputo KM, Byrick R, Chapman MG, Orser BJ, Orser BA. Intubation of SARS patients: infection and perspectives of healthcare workers. Can J Anaesth. 2006; 53:122–9.
crossref
34. Tien HC, Chughtai T, Jogeklar A, Cooper AB, Brenneman F. Elective and emergency surgery in patients with severe acute respiratory syndrome (SARS). Can J Surg. 2005; 48:71–4.
35. Dexter F, Parra MC, Brown JR, Loftus RW. Perioperative COVID-19 defense: an evidence-based approach for optimization of infection control and operating room management. Anesth Analg. 2020; 131:37–42.
crossref
36. Cook TM. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review. Anaesthesia. 2020; 75:920–7.
crossref
37. The Vortex Approach: To airway management [Internet]. The Vortex Approach;[cited 2020 May 28]. Available from http://vortexapproach.org/.
38. Gong Y, Cao X, Mei W, Wang J, Shen L, Wang S, et al. Anesthesia considerations and infection precautions for trauma and acute care cases during the COVID-19 pandemic: recommendations from a task force of the Chinese Society of Anesthesiology. Anesth Analg. 2020; 131:326–34.
crossref
39. Zhong Q, Liu YY, Luo Q, Zou YF, Jiang HX, Li H, et al. Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study. Br J Anaesth. 2020; 124:670–5.
crossref
40. Uppal V, Sondekoppam RV, Landau R, El-Boghdadly K, Narouze S, Kalagara HKP. Neuraxial anaesthesia and peripheral nerve blocks during the COVID-19 pandemic: a literature review and practice recommendations. Anaesthesia. 2020; 75:1350–63.
crossref
41. Raboud J, Shigayeva A, McGeer A, Bontovics E, Chapman M, Gravel D, et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One. 2010; 5:e10717.
crossref
42. Ofner-Agostini M, Gravel D, McDonald LC, Lem M, Sarwal S, McGeer A, et al. Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series. Infect Control Hosp Epidemiol. 2006; 27:473–8.
crossref
43. Peng PW, Wong DT, Bevan D, Gardam M. Infection control and anesthesia: lessons learned from the Toronto SARS outbreak. Can J Anaesth. 2003; 50:989–97.
crossref
44. Kwan A, Fok WG, Law KI, Lam SH. Tracheostomy in a patient with severe acute respiratory syndrome. Br J Anaesth. 2004; 92:280–2.
crossref
45. Li W, Huang J, Guo X, Zhao J, Mandell MS. Anesthesia Management and Perioperative Infection Control in Patients With the Novel Coronavirus. J Cardiothorac Vasc Anesth. 2020; Advance Access published on Mar 29, 2020. doi: 10.1053/j.jvca.2020.03.035.
crossref
46. Greenland JR, Michelow MD, Wang L, London MJ. COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. Anesthesiology. 2020; 132:1346–61.
47. Liu DC, Koo TH, Wong JKK, Wong YH, Fung KS, Chan Y, et al. Adapting re-usable elastomeric respirators to utilise anaesthesia circuit filters using a 3D-printed adaptor - a potential alternative to address N95 shortages during the COVID-19 pandemic. Anaesthesia. 2020; 75:1022–7.
crossref
48. Zhang L, Li J, Zhou M, Chen Z. Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series. J Anesth. 2020; 34:599–606.
crossref
49. Wali A, Rizzo V, Bille A, Routledge T, Chambers AJ. Pneumomediastinum following intubation in COVID-19 patients: a case series. Anaesthesia. 2020; 75:1076–81.
crossref
50. Ahmad I, Wade S, Langdon A, Chamarette H, Walsh M, Surda P. Awake tracheal intubation in a suspected COVID-19 patient with critical airway obstruction. Anaesth Rep. 2020; 8:28–31.
51. Zhao S, Ling K, Yan H, Zhong L, Peng X, Yao S, et al. Anesthetic management of patients with COVID 19 Infections during emergency procedures. J Cardiothorac Vasc Anesth. 2020; 34:1125–31.
crossref
52. Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan’s Experience. Anesthesiology. 2020; 132:1317–32.
53. Morau E, Bouvet L, Keita H, Vial F, Bonnet MP, Bonnin M, et al. Anaesthesia and intensive care in obstetrics during the COVID-19 pandemic. Anaesth Crit Care Pain Med. 2020; 39:345–9.
crossref
54. Odor PM, Neun M, Bampoe S, Clark S, Heaton D, Hoogenboom EM, et al. Anaesthesia and COVID-19: infection control. Br J Anaesth. 2020; 125:16–24.
crossref
55. Chen R, Zhang Y, Huang L, Cheng BH, Xia ZY, Meng QT. Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients. Can J Anaesth. 2020; 67:655–63.
crossref
56. Lee JS, Goy RW, Sng BL, Lew E. Considerations and strategies in the organisation of obstetric anaesthesia care during the 2019 COVID-19 outbreak in Singapore. Int J Obstet Anesth. 2020; 43:114–7.
crossref
57. Lee-Archer P, von Ungern-Sternberg BS. Pediatric anesthetic implications of COVID-19-A review of current literature. Paediatr Anaesth. 2020; 30:136–41.
58. He Y, Wei J, Bian J, Guo K, Lu J, Mei W, et al. Chinese Society of Anesthesiology Expert Consensus on Anesthetic Management of Cardiac Surgical Patients with suspected or confirmed Coronavirus Disease 2019. J Cardiothorac Vasc Anesth. 2020; 34:1397–401.
crossref
59. Thornton M, Reid D, Shelley B, Steven M. Management of the airway and lung isolation for thoracic surgery during the COVID-19 pandemic: Recommendations for clinical practice endorsed by the Association for Cardiothoracic Anaesthesia and Critical Care and the Society for Cardiothoracic Surgery in Great Britain and Ireland. Anaesthesia. 2020; 75:1509–16.
60. Şentürk M, El Tahan MR, Szegedi LL, Marczin N, Karzai W, Shelley B, et al. Thoracic anesthesia of patients with suspected or confirmed 2019 novel coronavirus infection: preliminary recommendations for airway management by the European Association of Cardiothoracic Anaesthesiology Thoracic Subspecialty Committee. J Cardiothorac Vasc Anesth. 2020; 34:2315–27.
crossref
61. Sharma D, Rasmussen M, Han R, Whalin M, Davis M, Kofke WA, et al. Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement From Society for Neuroscience in Anesthesiology & Critical Care (SNACC): Endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional Surgery (SNIS), Neurocritical Care Society (NCS), European Society of Minimally Invasive Neurological Therapy (ESMINT) and American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) Cerebrovascular Section. J Neurosurg Anesthesiol. 2020; 32:193–201.
62. Flexman AM, Abcejo AS, Avitisian R, De Sloovere V, Highton D, Juul N, et al. Neuroanesthesia practice during the COVID-19 pandemic: recommendations from Society for Neuroscience in Anesthesiology and Critical Care (SNACC). J Neurosurg Anesthesiol. 2020; 32:202–9.
crossref
63. Prince AD, Cloyd BH, Hogikyan ND, Schechtman SA, Kupfer RA. Airway Management for Endoscopic Laryngotracheal Stenosis Surgery During COVID-19. Otolaryngol Head Neck Surg. 2020; 163:78–80.
crossref
64. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E. Institute of Medicine, Board on Health Care Services, Committee on Standards for Developing Trustworthy. In: Clinical Practice Guidelines We Can Trust. Washington DC: The National Academies Press;2011. p. 290.
65. Dagens A, Sigfrid L, Cai E, Lipworth S, Cheung V, Harris E, et al. Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review. BMJ. 2020; 369:m1936.
crossref
66. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336:924–6.
crossref
67. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008; 336:995–8.
crossref
68. Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020; 21:100331.
crossref
69. American College of Surgeons. COVID-19: Guidance for Triage of Non-Emergent Surgical Procedures [Internet]. Chicago: ACS;2020 Mar 17 [cited 2020 May 28]. Available from https://www.facs.org/covid-19/clinical-guidance/triage.
70. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020; 323:1239–42.

Table 1.
Summary of AGREE II Results on National Anesthesia Guidelines for the Management of a COVID-19 Patient
AGREE II Domains Australia/ New Zealand Canada China India Italy South Africa South Korea Taiwan UK US
Domain 1 Scope and purpose 63.9 27.8 75.0 50 44.4 61.1 66.7 44.4 66.7 63.9
Domain 2 Stakeholder involvement 58.3 33.3 69.4 58.3 58.3 69.4 58.3 58.3 63.9 58.3
Domain 3 Rigor of development 11.5 3.1 22.9 13.5 8.3 15.6 13.5 17.7 25.0 19.8
Domain 4 Clarity of presentation 69.4 41.7 69.4 58.3 63.9 77.8 61.1 52.8 83.3 63.9
Domain 5 Applicability 39.6 25.0 43.8 27.1 31.3 50.0 29.2 35.4 43.8 31.3
Domain 6 Editorial Independence 0.0 0.0 0.0 41.7 0.0 0.0 82.6 0.0 0.0 0.0

Values are presented as percentage.

Spearman correlation analysis of reviewer scores of all domain items demonstrated good inter-rater reliability; ρ = 0.714 (P < 0.001, 95% CI: 0.436–0.868).

Table 2.
Comparison of National Guidelines on the Perioperative Preparation and Management of a Suspected/Confirmed COVID-19 Patients
Country Australia [10,11] Canada [12,13] China [1416] India [17] Italy [18,19] South Africa [20] South Korea [21] Taiwan [22] UK [23,24] US [2528]
Training Donning & doffing PPE Donning & doffing PPE Donning & doffing PPE; Streaming lectures online Donning & doffing PPE Donning & doffing PPE Donning & doffing PPE Donning & doffing PPE Donning & doffing PPE Donning & doffing PPE Donning & doffing PPE
Simulation e.g. Category 1 Caesarean delivery, airway crisis, major hemorrhage e.g. airway emergency e.g. Category 1 Caesarean delivery Intubation/ extubation drills wearing PPE Possible scenarios and multi-disciplinary teams Not stated Not stated Not stated e.g. Category 1 Caesarean delivery e.g. Category 1 Caesarean delivery & airway crisis
Prioritization Postpone elective surgery. Pandemic surgical framework Not stated Postpone elective surgery Defer elective/ semi-emergency surgery Not stated Surgery based on acuity. Postpone elective surgery Not stated Not stated Postpone elective surgery Postpone elective surgery, surgical review committee
Patient screening History taking including respiratory symptoms; appropriate triage & prompt isolation of patients Perform airway assessment with PPE on Elective cases History taking (including fever, cough, sore throat and travel history) should be elicited Not stated Preoperative screening for acute respiratory illness, pneumonia, contact and travel history, contact with healthcare facility managing COVID-19 patients Not stated Not stated MACOCHA score to predict difficult intubation and prepare strategy Screen patient for fever, cough, dyspnea, diarrhea & contact history
Telemedicine for anesthesia consult History (travel & contact history, respiratory symptoms) & examination Actively counsel patient to postpone elective surgery Phone or video assessment for pre-anesthesia encounter
Referral to infection control if temp > 37.3℃ PCR Testing based on population prevalence
Emergency cases
As above plus Chest Xray or CT
Resource planning Team-brief Not stated Smaller group to lead airway management in COVID-designated hospitals Multiple tracheal intubation teams Team-brief Team of 5 : 3 in OT and 2 outside as runners Replace anesthesia team every 2 hours to avoid fatigue Not stated Team-brief; Communication checklist; Cognitive aid Team-brief; Communication checklist
Smaller group to lead airway management Standby doctor with donned PPE outside chamber COVID cart with equipment & drugs Exclude high-risk staff during airway management
OT Negative pressure isolation room Negative pressure isolation room Negative pressure isolation room Designated OT with filters (lack of negative pressure OT) with dedicated anesthesia machine Negative pressure isolation room Negative pressure OT Negative pressure OT Not stated Negative pressure OT with > 12 air changes Designated negative pressure isolation OT
Warning signs on OT doors Warning signs on OT doors Warning signs on OT doors Warning signs on OT doors Warning signs on OT doors Warning signs on OT doors
Patient transfer To OT with surgical mask Not stated To OT with surgical mask Do not keep patient in holding area Direct route to OT with surgical mask Direct route to OT with surgical mask. Plan ahead for patient transfer. Not stated To OT with surgical mask To OT with surgical mask
Porters to clear the path Do not keep patient in holding area Do not keep patient in holding area Do not keep patient in holding area
Infection control Airborne precautions Airborne precautions Airborne precautions Airborne precautions Airborne precautions Airborne precautions Airborne precautions Airborne precautions Airborne precautions Airborne precautions
PPE N95 mask, face shield or goggles, gown, hat, double gloves for airway procedures N95 mask or PAPR, face shield or goggles, gown, hat, double gloves N95 mask or PAPR, face shield or goggles, gown, shoe covers, hood, and double gloves N95/N99 mask, eye protection, gown, boot covers, hat, double gloves N95 mask or PAPR device, face shield or goggles, gown, shoe covers, and double gloves N95 mask, face shield or goggles, gown, shoe covers, and double gloves (PAPR for intubation & extubation) N95 mask, face shield or goggles, protective coverall/ body suit, shoe covers, and double gloves (PAPR for intubation & extubation) N95 mask or PAPR device, face shield or goggles, gown, and double gloves N95 mask, eye protection, gown, double gloves N95 mask or PAPR device, face shield or goggles, gown, and double gloves
PAPR only for trained staff or if performing multiple procedures Buddy System when donning PPE Buddy System when donning PPE Hand hygiene is essential before donning and after doffing PPE Buddy System when donning PPE Use “anti-fog” for goggles Not stated Buddy System when donning PPE Buddy System when donning PPE Buddy System when donning PPE
Buddy System when donning PPE Hand hygiene is essential before donning and after doffing PPE Hand hygiene is essential before donning and after doffing PPE Hand hygiene is essential before donning and after doffing PPE Buddy System when donning PPE Hand hygiene is essential before donning and after doffing PPE Hand hygiene is essential before donning and after doffing PPE Hand hygiene is essential before donning and after doffing PPE Hand hygiene is essential before donning and after doffing PPE
Hand hygiene is essential before donning and after doffing PPE Hand hygiene is essential before donning and after doffing PPE
Staff to handover all personal belongings to buddy/runner to avoid them becoming fomites
Equipment 2 viral filters placed in circuit Hydrophobic/ HEPA filter between circuit & ETT 2 viral filters placed in circuit (between ETT & circuit; & between circuit & machine) 2 viral filters placed in circuit (between ETT & circuit; & between circuit & machine) Filter placed in circuit High efficiency Hydrophobic filter on every oxygen interface HEPA filter between circuit & ETT HEPA filter between circuit & ETT HME filter between catheter mount & circuit HEPA or HME filter between circuit & ETT, gas sampling tubing protected by HEPA filter
Forced air warming blankets only in intubated patients Use disposable equipment if possible Use disposable equipment if possible Dedicated equipment Preload closed suction device on anesthesia circuit Use disposable equipment if possible Use disposable equipment if possible Create a COVID-19 tracheal intubation trolley Use disposable equipment if possible
Use disposable equipment if possible Use disposable equipment if possible Use disposable equipment if possible Use disposable equipment if possible

PPE: personal protective equipment, MACOCHA: Mallampati III/IV, sleep apnea, decreased cervical mobility, mouth opening < 3 cm, Coma GCS < 8, severe Hypoxemia, practitioner not an Anesthetist. CT: computed tomography, PCR: polymerase chain reaction, OT: operating theatre, PAPR: powered air-purifying respirator, HEPA: high-efficiency particulate air, ETT: endotracheal tube, HME: heat and moisture exchanger.

Table 3.
Comparison of National Guidelines for the Intraoperative Management of a Suspected/Confirmed COVID-19 Patient
Country Australia [10,11] Canada [12,13] China [1416] India [17] Italy [18,19] South Africa [20] South Korea [21] Taiwan [22] UK [23,24] US [2528]
Anesthesia Technique Regional technique where possible Not stated Regional technique where possible Regional technique where possible Not stated Not stated Not stated Not stated Not stated Regional technique where possible
Induction Limit staff present due to potential aerosolization Limit staff present due to potential aerosolization Limit staff present due to potential aerosolization Limit staff present due to potential aerosolization Limit staff present due to potential aerosolization Limit staff present due to potential aerosolization Not stated Not stated Limit staff present due to potential aerosolization Limit staff present due to potential aerosolization
Airway Management Most experienced clinician Most experienced clinician Most experienced clinician Most experienced clinician Most experienced clinician Most experienced clinician Most experienced clinician Not stated Most experienced clinician. Most experienced clinician
Intubation Use of video- laryngoscope; optimize position Use of video- laryngoscope Use of video- laryngoscope (Asleep fiberscope intubation by trained staff) Use of video- laryngoscope Use of video- laryngoscope Use of video- laryngoscope with pre-loaded introducer Use of video- laryngoscope Use of video- laryngoscope Use of video- laryngoscope; optimize position Use of video- laryngoscope
Clear plastic cover over patient
R냐 RSI RSI RSI RSI (modified) RSI RSI RSI RSI RSI
(Intubation recommended over SAD) Introducer for intubation (stylet/bougie) Consider induction with Ketamine or use vasopressors in hemodynamic instability Consider induction with Ketamine or use vasopressors in hemodynamic instability
Neuromuscular blocker Neuromuscular blockade Neuromuscular blockade Neuromuscular blockade Neuromuscular blockade Neuromuscular blockade Neuromuscular blockade Neuromuscular blockade Neuromuscular blockade Neuromuscular blockade
Avoid PPV until ETT cuff inflation. Disconnect mask & HME from circuit to avoid ongoing flow of oxygen out through filter Avoid PPV until ETT cuff inflation Avoid PPV until ETT cuff inflation Avoid PPV until ETT cuff inflation Avoid PPV until ETT cuff inflation Avoid PPV until ETT cuff inflation Not stated Avoid PPV until ETT cuff inflation Avoid PPV until ETT cuff inflation Avoid PPV until ETT cuff inflation
Ensure tracheal tube cuff pressure ≥ 5 cmH2O above peak inspiratory pressure
Awake fiberoptic intubation Avoid Not stated Avoid Avoid Avoid aerosol with topicalization Not stated Avoid; Avoid aerosol with topicalization Avoid Avoid Avoid
Rescue – Insert SAD if failed 2nd attempt
Difficult Airway Vortex approach Not stated Not stated Not stated Intubate through SAD with flexible endoscope After failed intubation Plan B: 2nd generation SAD; Plan C: Two-handed mask ventilation Not stated Not stated Safe, Accurate, Swift; emergency FONA (Scalpel bougie); Consider intubation via SAD (blind/ bronchoscope assisted) Not stated
Surgical airway if cannot intubate and oxygenate CICO, for early cricothyroidotomy Plan D: emergency FONA
Supraglottic airway device (SAD) Insert SAD if failed intubation (2nd generation SAD preferred) SAD for airway rescue SAD preferred to intubation to minimize coughing at extubation For airway rescue Insert SAD if failed intubation (2nd generation SAD preferred) SAD for airway rescue For manual ventilation instead of face mask ventilation SAD for airway rescue 2nd generation SAD preferred. Not stated
Careful patient selection; controlled ventilation & low peak airway pressures; Intubate if leak is significant
Methods of oxygenation Avoid HFNO; minimize sedation & supplemental oxygen; lung protective ventilation Avoid HFNO & non-invasive ventilation Not stated Avoid high flow oxygen Use nasal apneic oxygenation 3 L/min Balance risk of viral transmission vs HFNO Avoid high-flows and extreme positive pressure ventilation Avoid high flows and HFNO Avoid HFNO & non-invasive ventilation Avoid HFNO & non-invasive ventilation Not stated
Extubation Closed loop suctioning; Prophylactic antiemetics to minimize vomiting Closed-loop suctioning Closed-loop suctioning; prophylactic antiemetics to minimize vomiting Closed-loop suctioning Consider antiemetics Not stated Consider glycopyrrolate or atropine to minimize secretions Closed-loop suctioning; consider opioids, lidocaine/ dexmedetomidine Closed-loop suctioning; Prophylactic antiemetics to minimize vomiting and possible viral spread.
Deep extubation, Consider opioids, lidocaine/ Cover patient’s nose and mouth with wet gauze Plastic sheet to reduce droplet dispersion
Dexmedetomidine
SAD exchange to avoid coughing
Recovery of patient Recover in OT; Surgical mask placed over oxygen mask Not stated Recover in OT Patient to wear surgical mask; oxygen mask over surgical mask Not stated Recover in OT Recover in OT Not stated Recover in OT Recover in OT
Surgical mask placed over oxygen mask/nasal prong Surgical mask placed over oxygen mask/nasal prong
Ventilators on standby for circuit disconnection

RSI: rapid sequence induction, SAD: supraglottic airway device, PPV: positive pressure ventilation, ETT: endotracheal tube, HME: heat and moisture exchanger, CICO: cannot intubate cannot oxygenate, FONA: front of neck access, HFNO: high flow nasal oxygen, OT: operating theatre.

Table 4.
Comparison of National Guidelines for the Postoperative Management of a Suspected/ Confirmed COVID-19 Patient
Country Australia [10,11] Canada [12,13] China [1416] India [17] Italy [18,19] South Africa [20 South Korea [21] Taiwan [22
Patient transfer ICU transfer plan; minimize circuit disconnection; clamp ETT, paralyze before disconnection Minimize circuit disconnection, clamp ETT Single-use Ambu bags preferred for intubated patients, avoid ventilator use Single-use Ambu bag preferred for intubated patients; Minimize circuit disconnection, clamp ETT; ventilator on standby Not stated Not stated Not stated
Use dedicated lift and lobby
Post-operative cleaning & disinfection OT cleaning as per local protocol As per hospital terminal cleaning protocol Environmental disinfection Environmental disinfection Not stated Not stated Not stated OT cleaning as per local protocol
Maintain airborne precautions for staff entering OT for at least 30 min (2–3% hydrogen peroxide spray disinfection, 2–5 g/L chlorine disinfectant/75% alcohol wiping of solid surfaces of equipment & floor) (2–3% hydrogen peroxide, 2–5 g/L chlorine disinfectant/75% alcohol wiping of solid surfaces of equipment & floor)
Post-op handling of equipment Waste disposal in labelled bins Waste disposal in labelled bins Waste disposal in labelled bins (double-bagged) Waste disposal in labelled bins (double-bagged) Waste disposal in labelled bins Dispose all used airway equipment in double zip-locked bag Dispose all used airway equipment in double zip-lock bag Dispose all used airway equipment in double zip-lock bag
Replacement of filters & breathing circuits; seal equipment in zip-lock bag Replace end-tidal carbon dioxide sample lines & traps Replace end-tidal carbon dioxide sample lines & traps
Debriefing Debriefing post event Timely feedback, encourage incident reporting Not stated Not stated Debriefing post event Not stated Not stated Not stated
Staff monitoring & welfare Staff: complete logbook of clinical exposures Not stated Daily temperature check: monitor respiratory symptoms and inform occupational med team. Social distancing measures for staff Not stated Not stated Not stated Not stated
Regular communication updates Wellness resources May require blood tests and chest CT, consider isolation Wellness resources on mental health and communicating with empathy
Consider influenza vaccination
Pregnant staff deployed to areas away from COVID-19 patients
Wellness resources

ICU: intensive care unit, ETT: endotracheal tube, OT: operating theatre, CT: computed tomography.

TOOLS
Similar articles